Stay updated on Belumosudil for Idiopathic Pulmonary Fibrosis Clinical Trial

Sign up to get notified when there's something new on the Belumosudil for Idiopathic Pulmonary Fibrosis Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Belumosudil for Idiopathic Pulmonary Fibrosis Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    8 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.15.0 to version 2.15.2.
    Difference
    0.0%
    Check dated 2025-05-01T06:13:51.000Z thumbnail image
  3. Check
    15 days ago
    No Change Detected
  4. Check
    22 days ago
    Change Detected
    Summary
    The web page has undergone significant changes, including the removal of detailed descriptions of a Phase 2 study for the drug belumosudil in treating Idiopathic Pulmonary Fibrosis (IPF), while retaining some key identifiers like the study name KD025-207 and the revision number.
    Difference
    31%
    Check dated 2025-04-16T20:23:49.000Z thumbnail image
  5. Check
    30 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.14.3 to version 2.14.4.
    Difference
    0.0%
    Check dated 2025-04-09T13:25:16.000Z thumbnail image
  6. Check
    37 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.14.2 to version 2.14.3.
    Difference
    0.0%
    Check dated 2025-04-01T23:59:46.000Z thumbnail image
  7. Check
    73 days ago
    Change Detected
    Summary
    The page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.
    Difference
    0.7%
    Check dated 2025-02-24T23:00:02.000Z thumbnail image
  8. Check
    88 days ago
    Change Detected
    Summary
    The web page now includes a notice about heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.
    Difference
    0.7%
    Check dated 2025-02-10T16:21:14.000Z thumbnail image

Stay in the know with updates to Belumosudil for Idiopathic Pulmonary Fibrosis Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Belumosudil for Idiopathic Pulmonary Fibrosis Clinical Trial page.